Results 211 to 220 of about 120,872 (251)

Management Challenges of Acute Promyelocytic Leukemia in Pregnancy: A Case Report. [PDF]

open access: yesJ Investig Med High Impact Case Rep
Hemry J   +4 more
europepmc   +1 more source

Asciminib and pulsed ATRA as post-remission therapy in T315I mutated PML-RARA-positive blast crisis of chronic myeloid leukemia. [PDF]

open access: yesAnn Hematol
Mazzarella R   +17 more
europepmc   +1 more source

Primary Indolent Acute Promyelocytic Leukemia. [PDF]

open access: yesHematol Rep
Wolfenbarger B   +4 more
europepmc   +1 more source

Promyelocytic leukemia protein: an atherosclerosis suppressor protein?

Clinical Science, 2021
As many as 70% of cells in atherosclerotic plaque are vascular smooth muscle cell (VSMC) in origin, and pathways and proteins which regulate VSMC migration, proliferation, and phenotype modulation represent novel targets for rational drug design to ...
Cali B. Corbett   +2 more
semanticscholar   +3 more sources

Acute promyelocytic leukemia and variant fusion proteins: PLZF-RARα fusion protein at a glance

Seminars in Oncology, 2019
Classical acute promyelocytic leukemia (APL) cases are associated with the promyelocytic leukemia-retinoic acid receptor α (PML-RARα) chimeric fusion protein. Almost all the variant chimeric proteins share the same RARα component. Currently, more than 11
Liaqat Hussain   +2 more
exaly   +2 more sources

Promyelocytic Leukemia Protein, a Protein at the Crossroad of Oxidative Stress and Metabolism

Antioxidants & Redox Signaling, 2017
Cellular metabolic activity impacts the production of reactive oxygen species (ROS), both positively through mitochondrial oxidative processes and negatively by promoting the production of reducing agents (including NADPH and reduced glutathione). A defined metabolic state in cancer cells is critical for cell growth and long-term self-renewal, and such
Sarah Tessier   +4 more
semanticscholar   +4 more sources

Home - About - Disclaimer - Privacy